Pasithea Therapeutics to Host Virtual NF1 Treatment Event November 4

Pasithea Therapeutics said Rebecca M. Brown, MD, and Kavita Sarin, MD, PhD, will join management to discuss unmet needs and the treatment landscape for NF1-associated neurofibromas.